Vir Biotechnology Inc. (VIR) Tops Q4 EPS by 23c
Tweet
Share
E-mail
Get Alerts VIR Hot Sheet
Join SI Premium – FREE
Vir Biotechnology Inc. (NASDAQ: VIR) reported Q4 EPS of ($0.31), $0.23 better than the analyst estimate of ($0.54). Revenue for the quarter came in at $64.07 million versus the consensus estimate of $1.42 million.
For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Murphy Oil announces oil discovery offshore Côte d'Ivoire
- Nakamoto closes healthcare clinics, completes shift to Bitcoin
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
